Researchers at Arizona State University’s Biodesign Institute and their collaborators have made a breakthrough in addressing this issue and taken a step that could enable DNA to serve as a building block for next-generation electronics. In a new study, a team demonstrated that by precisely controlling how metal ions bind within a DNA molecule, DNA can function as a fully electronic, chip-integrated memory system that is directly compatible with conventional electronics.
Category Archives: AZBio News
DecisionDx®-Melanoma’s i31-SLNB: Report from the Largest Prospective Multicenter Study to Date Confirms 2.6% Nodal Positivity in Patients Predicted to Have Less Than 5% Risk
- Study results were recently shared at the Society of Surgical Oncology (SSO) 2026 Annual Meeting in Phoenix.
- NCCN Cutaneous Melanoma Guidelines recommend avoiding a sentinel lymph node (SLN) biopsy (SLNB) if the predicted SLN positivity rate is less than 5%. This report shows that patients with a less than 5% predicted risk of SLN positivity by the DecisionDx-Melanoma test had an actual SLN positivity rate of just 2.6%, and only 1.4% in patients with T1b–T2a tumors specifically, again confirming the clinically actionable performance of DecisionDx-Melanoma.
AZBio Member Spotlight – SynCardia Systems, LLC
SynCardia Systems, LLC is a medical technology company focused on addressing the most severe and underserved form of heart failure, when both sides of the heart fail, and patients have no other treatment options. The company is working to provide life-saving solutions for patients facing end-stage biventricular heart failure.Continue reading
University of Arizona remembers former President Eugene G. Sander
Former University of Arizona President Eugene G. Sander passed away Feb. 22. He was 90.Continue reading
FDA Permits NuvOx Therapeutics to Initiate Phase II REBORN Trial of NanO2 in Recurrent High-Grade Glioma
Tucson, AZ –March 4, 2026, NuvOx Therapeutics, Inc. (“NuvOx”) today announced that the U.S. Food and Drug Administration (FDA) has authorized NuvOx to proceed with a new Phase II clinical trial evaluating NuvOx’s product candidate NanO2 (the active pharmaceutical ingredient of which is dodecafluoropentane) for the treatment of recurrent high-grade gliomas.Continue reading
Cinova Medical Acquires Elastomer Technologies, Inc.
Cinova Medical announced the acquisition of Elastomer Technologies, Inc. (ETI), a Southern California–based custom molder of liquid silicone rubber (LSR) and high-consistency gum rubbers serving the medical device and life sciences industries. ETI will continue operating from its current facility while Cinova Medical completes the expansion of a new Class 8 cleanroom dedicated to silicone molding. Upon completion, ETI’s manufacturing operations will be integrated into Cinova’s expanded production footprint. Headquartered in Phoenix, AZ, Cinova Medical is a vertically integrated contract manufacturer of precision-engineered, high-quality injection-molded and machined components, as well as complex Class II finished (sterile) medical devices.Continue reading
Senate Passes SBIR Reauthorization
On Tuesday, March 3, 2026, the Senate Unanimously Passed the Senate Bill 3971, the Small Business Innovation and Economic Security Act, that would extend the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs through Sept. 30, 2031. The measure now moves to the U.S. House of Representatives for final approval. Continue reading
Arizona Senate Recognizes 30 Years of Impact by the Velley Fever Center for Excellence
Dr. John Galgiani, professor of medicine and director of the University of Arizona Valley Fever Center for Excellence accepted an Arizona Legislative Proclamation on behalf of the team at the Valley Fever Center for Excellence.
Valley Fever is a dangerous and potentially fatal disease. More than half of all U.S. cases are reported in the state of Arizona.Continue reading
AZ House HHS Testimony Supporting the Arizona Health Innovation Trust Fund
HB 2727: appropriations; health innovation trust fund is sponsored by Representative Selina Bliss, Chairman of the Arizona House of Representatives Health and Human Services Committee (H-HHS) and co-chair of the Arizona Bioscience and Healthcare Caucus. House Bill 2727 was heard in H-HHS on February 2, 2026. The bill passed out of committee with a Do Pass recommendation on a vote of Continue reading
Tales from The Road – Terrence Stull, MD – Founder of BacVax
Listen in as Dr. Terry Stull shares his journey from academic medicine and clinical research leadership to biotech entrepreneurship.Continue reading